Capabilities

Manufacturing at national scale.

Bulk drug substance, sterile fill-finish, and a monitored cold chain, under one quality system.

Upstream
0
Litres installed capacity
Fill-finish
0
Units per year
Distribution
0
Pallet positions
Quality
0
Automated inspection
CDMO Services

End-to-end manufacturing.

Scale biomanufacturing

Single-use bioreactor trains from clinical to commercial volumes.

Accelerate development

Process development that shortens the path to a locked, validated process.

De-risk market entry

Regulatory and quality support that carries a product across borders.

Integration

The integrated value chain.

01
Advisory
Target selection and process strategy.
02
Innovation
Cell line, process and analytics development.
03
Manufacturing
Commercial supply and lifecycle support.
Digital Twin

Adjuvant Bio Biomanufacturing Facility

Interactive facility overview. Select a system on the floor plan or the list to view technical specifications.

A - Upstream B - Downstream C - Fill-Finish D - QC Analytics 22.4°C pH 7.2 BR-01 · 20kL Fed-Batch 36.8°C DO 42% BR-02 · 20kL Perfusion Δp 0.3 bar CHR-01 · FPLC IEX+SEC UF/DF-01 TFF 30m² ISO 5 ΔP +15Pa FF-01 Isolator −50°C <1% RH LYO-01..04 ENV:OK 24/7 QC-01 · HPLC+MS USP/EP EMS-01 VIABLE+NVC

Interactive floor plan. Select a zone to view specifications.

System Specifications

Select a zone on the facility map or choose below.

Bring a molecule to the line.

From tech transfer to commercial supply, on one platform.